经导管主动脉瓣置换术围术期严重并发症的单中心经验分析
本研究为单中心回顾性研究,纳入2016年5月至2020年11月在北战区总医院行TAVR的AS患者119例,观察围术期严重并发症,并以每30例为区间分析术者经验积累的影响。结果显示围术期严重并发症共39人次,全因死亡0.8%,永久起搏器置入11.8%,瓣中瓣植入6.7%;多数并发症发生在开展TAVR前期,经验积累可降低全因死亡、冠状动脉闭塞及外周血管入路并发症发生率,但起搏器置入及瓣中瓣植入未见明显下降。
要点
- TAVR围术期严重并发症多集中于开展前期,经验积累后部分并发症减少。
- 全因死亡、冠脉闭塞及外周血管入路并发症随经验积累呈下降趋势。
- 永久起搏器置入(11.8%)与瓣中瓣植入(6.7%)发生率未随经验明显下降。
核心结论
- 本中心多数严重并发症发生在开展TAVR治疗的前期。
- 学习阶段的TAVR中心通过经验积累可降低围术期全因死亡、冠状动脉闭塞、外周血管入路并发症发生率。
- 起搏器置入及植入瓣中瓣的发生率未见明显下降。
研究设计与样本
- 单中心回顾性研究,纳入2016年5月至2020年11月于北部战区总医院行TAVR的AS患者119例,男性64例,平均年龄(73.9±6.9)岁。
- 记录围术期严重并发症,并以每30例患者为一个区间统计并发症发生情况、绘制柱形图以观察术者经验积累的影响。
主要发现
- 119例中瓣膜植入不成功3例(2.5%)。
- 围术期发生严重并发症共39人次,其中全因死亡1例(0.8%)、转外科开胸2例(1.7%)、冠状动脉闭塞2例(1.7%)、外周血管入路并发症8例(6.7%)、新发严重脑血管事件1例(0.8%)、中度及以上瓣周漏3例(2.5%)、因瓣膜移位植入瓣中瓣8例(6.7%)、因新发房室传导阻滞行永久起搏器置入14例(11.8%)。
- 柱形图显示,置入永久心脏起搏器、植入瓣中瓣的发生率随术者经验积累未见明显下降,其余并发症在30例之后发生频次呈下降趋势。
临床怎么用
- 开展TAVR初期应警惕全因死亡、冠状动脉闭塞及外周血管入路并发症,随着经验积累上述并发症可减少。
- 起搏器置入及瓣中瓣植入发生率未随经验下降,需持续关注并优化相关策略。
局限性
- 本研究为单中心回顾性研究,样本量有限(119例),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To observe the incidence of perioperative severe complications in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVR), and to explore the influence of the accumulated experience of the operators on the incidence of complications. Methods: This is a single-center retrospective study. Patients with AS who underwent TAVR from May 2016 to November 2020 in General Hospital of Northern Theater Command were included. The occurrence of severe complications during perioperative period was recorded. Severe complications included all-cause death, surgical transfer to thoracotomy, coronary artery occlusion, peripheral vascular approach complications, severe cerebrovascular events, moderate or above perivalvular leakage, valve displacement (implanted valve middle valve), pacemaker implantation, etc. In order to observe the influence of the accumulated experience of the operators on the occurrence of postoperative complications, the complications in each stage of the patients were counted and the bar chart was drawn with interval of every 30 patients. Results: A total of 119 patients were included, including 64 males and 55 females, the mean age was (73.9±6.9) years. The valve implantation was unsuccessful in 3 out of 119 patients (2.5%). There were 39 cases of severe complications during perioperative period, including 1 death (0.8%), 2 cases of thoracotomy (1.7%), 2 cases of coronary artery occlusion (1.7%), 8 cases of peripheral vascular approach complications (6.7%), and 1 case of new severe cerebrovascular event (0.8%), 3 cases of moderate or higher perivalvular leakage (2.5%), 8 cases of valve displacement leads to midvalvular implantation (6.7%), 14 cases of permanent pacemaker implantation due to new atrioventricular block (11.8%). The bar chart showed that the incidence of permanent pacemaker implantation and in-valve implantation did not significantly decrease with the accumulation of experience, while the incidence of other complications showed a decreasing trend after 30 cases. Conclusions: Most serious complications occurred in the early stage of TAVR in our center. The incidence of all cause death, coronary artery occlusion and peripheral vascular approach complications in the perioperative period post TAVR could be reduced in the TAVR center in the learning stage through the accumulation of procedure-related experience, but the incidence of pacemaker placement and the implanted valve within the valve dose not significantly decrease over time. 目的: 观察接受经导管主动脉瓣置换术(TAVR)治疗的主动脉瓣狭窄(AS)患者围术期严重并发症发生情况,并探索术者经验积累对手术并发症发生情况的影响。 方法: 本研究为单中心回顾性研究。纳入2016年5月至2020年11月于北部战区总医院住院行TAVR的AS患者。记录患者围术期严重并发症的发生情况,严重并发症包括全因死亡、转外科开胸、冠状动脉闭塞、外周血管入路并发症、严重脑血管事件、中度及以上瓣周漏、瓣膜移位(植入瓣中瓣)、起搏器置入等。为观察术者经验累积对患者术后并发症发生情况的影响,依据实施手术的先后顺序,以每30例患者为一个区间,分别统计各区间患者发生并发症的情况,并绘制柱形图。 结果: 共纳入119例患者,其中男性64例,年龄(73.9±6.9)岁。在119例患者中,瓣膜植入不成功3例(2.5%)。围术期发生严重并发症共39人次,其中全因死亡1例(0.8%),转外科开胸2例(1.7%),冠状动脉闭塞2例(1.7%),外周血管入路并发症8例(6.7%),新发严重脑血管事件1例(0.8%),术后中度及以上瓣周漏3例(2.5%),因瓣膜移位植入瓣中瓣8例(6.7%),因新发房室传导阻滞行永久起搏器置入14例(11.8%)。柱形图显示,置入永久心脏起搏器、植入瓣中瓣的发生率随术者经验积累未见明显下降,其余并发症在30例之后发生频次呈下降趋势。 结论: 多数并发症发生在开展TAVR治疗的前期;处于学习阶段中的TAVR中心,通过一定经验的积累,可以降低TAVR围术期全因死亡、冠状动脉闭塞、外周血管入路并发症的发生率,但起搏器置入及植入瓣中瓣的发生率未见明显下降。.
引用
- Zheng LF, Xu K, Wang B, et al. [Perioperative serious complications in patients undergoing transcatheter aortic valve replacement: a single-center experience]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 34404184. doi:10.3760/cma.j.cn112148-20210422-00364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。